Crinetics Pharmaceuticals gets grant for patent granted for somatostatin modulators for treating hormone-related conditions

Discover how Crinetics Pharmaceuticals Inc's patent for compounds modulating somatostatin activity can suppress hormone secretion in mammals. Explore the detailed framework for hormone modulation and SSTR2 activity regulation.

Related Posts

Rats have an imagination, too, researchers show with br...

Nov 3, 2023

Ultimovacs bags orphan drug tag for mesothelioma vaccine

Oct 9, 2023

Precision and Imugene conclude transaction for cancer d...

Aug 16, 2023